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STUDIES ON THE MODE OF ACTION OF VITAMIN A*
PETER FLESCH, M.D., Pn.D.
Although there is a voluminous literature on the use of large doses of vitamin
A in the treatment of diseases characterized by excessive or abnormal keratiniza-
tion (e.g. Darier's disease, pityriasis rubra pilaris, ichthyosis, calluses, keratoder-
mas, etc.), nothing definite is known about the mode of action of this vitamin in
cutaneous metabolism. It has been shown that vitamin A has an "anti-keratiniz-
ing" effect which is manifested in a number of ways: In vitro vitamin A prevents
the differentiation of epidermal cells into keratin in tissue cultures (1). In animals,
large doses of vitamin A given by mouth (2), or applied locally (3), interfere
with hair formation and cause reversible baldness. A decreased rate of keratin
formation was also suggested by observations made on rats after local applica-
tion of the vitamin (4). In human hypervitaminosis A, temporary loss of hair is
a common symptom (5). Finally, vitamin A frequently has been an excellent
therapeutic agent in the treatment of different types of anomalous keratinizing
processes (6).
The exact mechanism of this anti-keratinizing effect is unknown. Knowledge
of this mode of action may not only shed more light on the process of keratiniza-
tion, but may help us to understand the role of vitamin A in the metabolism of
the skin in general. Such an insight may also pave the way for the introduction
into dermatology of other, possibly more potent, stable and less expensive "anti-
keratinizing" compounds.
In our recent works on the depilatory effect of unsaturated lipoid-soluble com-
pounds, we have advanced a theory concerning the mode of action of large
amounts of vitamin A. We suggested that in such large amounts, vitamin A had
a direct, local and probably non-specific drug effect on the epidermal cells (7).
The anti-keratinizing action of vitamin A has been attributed by us to the un-
saturated double bonds in the molecule. We thought that vitamin A, by virtue
of its unsaturation, interfered with sulfhydryl metabolism in the same way as
other unsaturated, lipoid-soluble depilatory agents (8).
This theory had certain shortcomings. It left unexplained the fact that after
local application of vitamin A, hair loss occurred in animals only, while systemic
administration of excessive doses interfered with hair growth in animals and hu-
man subjects alike. The belief that vitamin A prevented hair growth by interfer-
ing with sulfhydryl metabolism, was not supported by experimental evidence, as
vitamin A palmitate had no effect on sulfhydryl compounds in vitro. We postu-
lated that maybe not vitamin A itself, but some of its degradation products were
responsible for the anti-keratinizing activity of vitamin A; such degradation
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products would probably also inactivate sulfhydryl compounds in vitro. This
belief, however, was without experimental foundation (8).
Recently Wald, in his studies on yisual purple, found that retinene1, which
is chemically vitamin A1 aldehyde, the carotenoid portion of rhodopsin, combined
with the free sulfhydryl groups of the protein opsin, the other component of
visual pigment. Retinene1 also combined with other sulfhydryl compounds (9).
This reaction took place rather slowly. It was obvious that our own previous
findings were in need of revision with the use of different derivatives of vitamin
A, tested in high concentrations.
The present paper attempts to shed light on the mechanism of the anti-
keratinizing action of large doses of vitamin A in the following ways:
1. In order to answer the question, whether or not there was a basic difference
between local and systemic depilation, we adminbtered to laboratory animals
an unsaturated compound by mouth. This compound, oleic acid, has been de-
scribed by us (8, 10), as well as by others (11) as having a local depilatory effect
in animals. If it were possible to show that such a depilatory effect could be
obtained by oral administration as well, it could be assumed that the two effects
were basically identical and that the same conditions may also apply to vita-
ininA.
2. In order to study the mode of action of vitamin A, we tested several of its
derivatives both for their depilatory effect in vivo and their sulfhydryl inactivat-
ing action in vitro in an attempt to find a correlation between chemical structure
and reactivity.
3. Finally, some of the vitamin A derivatives were subjected to clinical trial
on patients with ichthyosis.
EXPERIMENTAL
1. Oral administration of oleic acid to laboratory animals
Two groups of four albino rabbits each were given oleic acid (Merck) by stom-
ach tube. The first group received a total of 40 ml. of oleic acid, administered in 4
equal doses every other day; of the second group, 2 rabbits received 2 doses of
2.5 ml. of oleic acid and two received the same amount of ethyl oleate at 5 days'
intervals. The rabbits weighed 3 to 4 kg. Great care was taken not to contaminate
the skin in order to avoid the local depilatory effect of oleic acid or ethyl oleate.
Control experiments could not be carried out, because stearic acid, the saturated
derivative of oleic acid, is solid at room temperature and cannot be administered
by mouth, unless it is dissolved in a solvent. Introduction of a solvent would
have added another variable to the experimental procedure.
td. In vitro and in vise effects of vitamin A derivatives
a. Methyl, phenyl ethers and palmitic ester of vitamin A. The methyl and phenyl
ethers of vitamin A* were tested for their effect upon free sulfhydryl groups of
tissue proteins and upon the sulfhydryl enzyme, succinic dehydrogenase, by
* Received through the courtesy of Dr. Roger A. Lewis and Hoffmann-LaRoche, Inc.
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methods described in previous publications (12, 13). Buffered mouse liver homo-
genates were incubated with the alcoholic solutions of the ethers at room tempera-
ture for 15 minutes and the sulfhydryl content was compared with control
mixtures, containing the solvent instead of the vitamin A ethers. Similar experi-
ments were carried out with vitamin A palmitate. The concentrations of the vita-
min A ethers used were as follows: 88 to 350 g. of methyl or phenyl ether and
375 big. to 3 mg. (1250 to 10,000 units) of vitamin A palmitate. These were
added to 10 mg. (for —SH determinations) and 100 mg. (for succinic dehy-
drogenase determinations) of mouse liver in 10% buffered homogenates.
When using Bennett's reagent for sulfhydryl determinations in the presence of
these compounds or of the synthetic precursors to be discussed below, it is essen-
tial to set up control tubes containing the vitamin A derivatives in amy! acetate
solution without added tissues. We found that upon acidifying with concentrated
hydrochloric acid, as is required in the method, these solutions develop a more or
less marked and immediate dark color, ranging from purple to olive green, de-
pending on the compound and its concentration. This color development may
give rise to false readings. Several methods may be used to overcome this difil-
culty: one is to make the colorimetric readings immediately after addition of the
HC1, before color development can take place. This is effective with the synthetic
vitamin A precursors, but fails with higher concentrations of the esters of vitamin
A where the color appears immediately upon addition of 1101. In these instances
no HC1 was added; readings were made by comparing a blank control amyl ace-
tate solution containing vitamin A esters only with the supernatant amy! acetate
solution of Bennett's reagent obtained from the reaction mixture which contained
the tissue homogenate and the vitamin A ester. Although this procedure is less
sensitive than the standard method, described by us, in which HCI is added, it
is a permissible and adequate method and has been successfully used by other
workers (14).
b. In vivo studies. To two groups of 7 mice each, alcoholic solutions of the
methyl and phenyl ethers of vitamin A were administered locally on the backs
every other day for 10 days. The amount applied was ml. of a solution, con-
taining 1.75 mg. of ether/ml.* Control groups of animals were treated with
alcohol only. Not enough material was available for more extensive experiments.
3. Synthetic precursors of vitamin A. (Hydroxenin and oxenin)
Hydroxenin and oxenint are chemical intermediates in the manufacture of syn-
thetic vitamin A. From their chemical configuration (Fig. 1) it is readily visible
that these compounds differ from the esters of vitamin A in two respects: in the
distribution of the double bonds in the side chains and in having a free alcoholic
group at the end of the side chain. Since the isoprene-like chemical arrangement
of the double bonds in the side chain of vitamin A is essential for the vitamin
activity (15), these synthetic precursors have no vitamin A activity.
The physical properties of oxenin and hydroxenin are also different from those
* This amount corresponds approximately to 5500 I.TJ./cc.
f Received through courtesy of Dr. Elmer L. Sevringhaus and Hoffmann-LaRoche, Inc.
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of vitamin A alcohol or of its esters. Hydroxenin is a yellowish-white crystalline
material which is fairly stable at room temperature. Oxenin is a yellow amorphous
powder which is unstable at room temperature and colliquates after standing for
a short while. In solution, both substances deteriorate rapidly.
No extensive animal studies were made with these compounds. Previous ex-
perience with other unsaturated depilatory agents has taught us that hair loss
cannot be achieved by local application of solid material in alcoholic solutions to
the skin of laboratory animals: The alcohol evaporates, leaving a thin film of
inert material on the skin surface. This observation was confirmed also in the
case of oxenin and hydroxenin. Application in oily solvents was postponed, be-
cause of the scarcity of the available supplies and their use for clinical studies.
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Fia. 1. Synthetic precursors in the manufacture of Vitamin A acetate. (1) Oxenin (2)
Hydroxenin (3) Vitamin A Acetate.
a. In vitro studies. In vitro experiments concerning the effects of these com-
pounds on sulfhydryl groups and succinic dehydrogenase were performed in the
same way as described above for the ethers of vitamin A. Ten per cent mouse
liver homogenates (10 mg. for—SH determination and 100 mg. for succinic de-
hydrogenase) were incubated with 0.1 ml. of a 0.25 to 2 % alcoholic solution of
oxenin or hydroxenin at room temperature for 15 minutes. The colorimetric
readings were compared with control tubes containing the solvent instead of the
vitamin A precursors. Readings were made both before and immediately follow-
ing addition of concentrated HC1 to Bennett's reagent, in order to avoid the
interference of the secondary color development, as mentioned previously.
b. Clinical studies. Hydroxenin and oxenin were incorporated into cold cream
bases in a 5 % concentration. Sustane® (3-tertiary butyl-4-hydroxyanisole) was
added in 0.02 % final concentration as an antioxidant, to slow down the oxidative
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deterioration of the vitamin A derivatives. The ointments were applied daily to
the arms of patients with ichthyosis; the contralateral arm served as control and
was treated with the cold cream base only.
Because of the limited supplies available and in order to insure properly
continued treatment, only two patients could be tested with each ointment. The
patients \vere instructed to keep the ointments stored in the refrigerator between
treatments. The areas under treatment were checked every two weeks.
FIG. 2. Loss of hair on ear of rabbit after oral administration of oleic acid. Note fine
scaling. The black mark above the bald area is part of an identification tag.
RE5ULT5
1. Oral administration ofoleic acid to rabbits
Of the two groups of rabbits given oleic acid, only those receiving the higher
doses developed any hair loss. One animal in this group died; the others showed
no apparent ill effect except for the cutaneous symptoms to be described.
On the 5th to 7th day of the treatment, all surviving rabbits in this group
developed sealing "seborrheic" lesions on the outer sides of both ears. The
affected area was oval, about 1 x ij in. in diameter. The lesion was similar to
the early manifestations observed after local application of oleic acid; ho\vever,
the scaling was finer and there was no sign of cutaneous irritation. Shortly after
the onset of the scaling the hair began to fall out with the roots. The hair loss
was similar to that observed after local application of oleic acid (Fig. 2). It
was reversible in all cases.
No effect was noted in any of the animals after treatment with the smaller
doses of oleic acid or ethyl oleate.
426 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
2. In vitro and in vivo effects of the ethers of vitamin A
When used in sufficiently high concentrations, the methyl, phenyl ethers and
palmitic ester of vitamin A inactivated the —Sil groups of mouse liver homo-
genates and the sulfhydryl enzyme succinic dehydrogenase. The approximate
minimum concentrations which still cause a significant inhibition under our
experimental conditions are listed in Table I.
TABLE I
Inactivation of sulfhydryl compounds by ethers of vitamin A
CONCENTRATIONS OF ESTERS OF VITAMIN A
Methyl ether Phenyl ether Palmitic ester
—SR groups of 10 mg. liver...................... 90 pg 90 pg 300 pg
Succinic dehydrogenase activity of 100 mg. liver. . 175 pg 175 pg 1500 pg
Fia. 3. Reduction of scaling in ichthyosis after 4 weeks' treatment with 5% hydroxenin
ointment. Left: Control site treated with ointment base. Right: Central area treated with
hydroxenin ointment.
With higher concentrations the inhibition increased until complete inactiva-
tion was reached.
Among the two groups of mice treated locally with the ethers of vitamin A,
three of the animals receiving the methyl ether died within 1 week; the survivors
all lost their hair on the 10th day of the treatment. No changes were observed in
the group receiving the phenyl ether.
/
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3. Effects of hydroxenin and oxenin
a. In vitro effects. Both synthetic precursors of vitamin A inactivated the
sulfhydryl groups and succinic dehydrogenase of mouse liver. The approximate
amounts necessary to cause a minimal inactivation of the sulfhydryl groups of
10 mg. mouse liver were 500 Mg. of hydroxenin and 150 Mg. of oxenin. The minimum
amounts needed to inhibit the succinic dehydrogenase activity of 100 mg. of
mouse liver were 500 Mg. of either compound.
b. Clinical results. Two to three weeks after the beginning of the treatment,
both patients showed diminished scaling on the areas where hydroxenin ointment
had been applied. No change was observed on the control sites treated with the
ointment base (Fig. 3.). After improvement had set in, in one of the patients the
hydroxenin ointment was replaced with the ointment base, whereupon the scaling
returned in its former intensity. Upon resumption of the treatment with hydrox-
elm, the skin symptoms were alleviated again.
Inunction with oxenin ointment had no noticeable effect. Neither compound
caused any local or general untoward reaction.
DISCUSSION
Cutaneous changes in rabbits after oral administration of large amounts of
oleic acid have been described by Adler. With this method this author was able
to produce crusted lesions on the ears of the animals. It is probable that these
cutaneous changes were identical with those observed by us, although Adler
failed to describe the subsequent hair loss (16). Interference with hair growth
after internal as well as local administration of unsaturated depilatory compounds
strongly supports the view held by us that in either case the compound (oleic
acid or vitamin A) acts directly on the hair follicles. When given by mouth in
large amounts, these compounds or their degradation products saturate the
organism and it appears that they are partly excreted through the sebaceous
glands into the hair follicles and onto the skin surface. The observations of
Perutz and his coworkers strengthen this assumption. When these authors in-
jected the highly unsaturated cod liver oil into rabbits, the hair growth decreased
and the iodine number of the skin fats rose, as an indication of increased un-
saturation (17).
The question why the hair loss is limited to the ears cannot be answered at
present. The greater sensitivity of the hair follicles on the human scalp to a
variety of physical and toxic influences is a similar unsolved problem. Prelim-
inary histologic studies of the depilated ears of the rabbits have not yielded
any satisfactory explanation.
The finding that in vitro the ethers of vitamin A inactivate sulfhydryl com-
pounds is of theoretical as well as practical interest. This is the first instance
in which the chemical reactivity of the ethers of vitamin A toward proteins has
been demonstrated. The reaction is apparently not limited to retinene1, the
aldehyde of vitamin A1, but is a common property of various vitamin A deriva-
tives. Thus there is no more exception to the rule governing the depilatory action
of unsaturated, lipoid-soluble compounds: all these compounds inactivate sulf-
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hydryl groups in vitro, probably by virtue of their unsaturated groupings.
Saturation (hydrogenation) abolishes the in vivo depilatory and in vitro still-
hydryl inhibitory action. The reverse, however, does not hold true: many com-
pounds which interfere with sulfhydryl metabolism in vitro do not have any
effect on hair growth.
This sulfhydryl inhibitory activity of vitamin A could not be demonstrated
in our previous publications because the amounts of vitamin A ethers used were
not suciently large, never exceeding 1000 units in the reaction mixtures. In the
present work these amounts were increased 10 fold or more. The justifiable
criticism may be raised that these amounts are unphysiologic. It should be
remembered, however, that the amounts of vitamin A administered in keratiniz-
ing diseases are equally unphysiologic, surpassing the normal requirements 20 to
100 times. Even in Wald's in vitro studies on the reactivity of retinene1 toward
sulfhydryl compounds, 5 hours' incubation was necessary before the inactivation
could be effected (9). This is a very long period for biochemical studies of this
nature. In our work, 15 minutes' incubation was used routinely and it is likely
that the amounts of vitamin A ethers needed for sulfhydryl inactivation could
be reduced materially with longer periods of incubation.
The in vivo depilatory action of the ethers shows an interesting parallelism
with their other toxic effects. The methyl ether and palmitic ester cause depila-
tion and anomalous ossification, while the phenyl ether is inert in both respects
(18). It is conceivable that the phenyl ether cannot be broken down in the body
to the as yet unknown active degradation product which is believed to be re-
sponsible for the action of vitamin A (15).
The inhibition of epidermal keratin formation by hydroxenin offers evidence
in favor of the theory advanced by us that in large amounts vitamin A has a
nonspecific drug action. Hydroxenin has no vitamin A activity and yet it has the
same local effect as vitamin A has in large doses. The ineffectiveness of oxenin
as an anti-keratinizing agent is probably due to its unstable nature. Hydroxenin
has some of the desirable qualities which we were seeking: it is stable, cheaper
and cosmetically more desirable than vitamin A. It is not advocated that this
compound be used locally instead of vitamin A; our work merely indicates that
the therapeutic effects of vitamin A may be achieved with other unsaturated
compounds as well. Testing of such compounds is in progress.
On the basis of our present work, the following theory may be formulated
concerning the mode of action of vitamin A in cutaneous metabolism: Vitamin
A in excessive doses has a non-specific direct drug effect upon the epidermis; this
effect is probably connected with interference with cutaneous sulfhydryl metab-
olism. It appears likely that the anti-keratinizing action is due to some unknown
metabolite of vitamin A, since related compounds, like hydroxenin, have a
similar action. Whether or not the physiologic effects of vitamin A in cutaneous
metabolism are due to a similar mechanism, remains the object of future studies.
Our incidental finding that amyl acetate solutions of the vitamin A esters
develop a strong color in the presence of concentrated hydrochloric acid, makes
possible the development of a new colorimetric method for the quantitative
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estimation of vitamin A. Preliminary experiments indicate that the color follows
the Beer-law over a wide range. This new method has the advantage over the
Carr-Price estimation that the developed color is stable. The sensitivity of the
method is somethat low, but can be increased. Work to develop this method is in
progress and will be reported elsewhere.
SUMMARY
1. The mechanism of the "anti-keratinizing" (scale-preventing and depilatory)
action of large doses of vitamin A was studied in vitro and in vivo.
2. It has been claimed that the local and systemic depilatory effects of vitamin
A may be due to different mechanisms. In order to study the effect upon hair
growth of orally administered unsaturated compounds, another unsaturated,
local depilatory compound, oleic acid, was given to rabbits by mouth. When
administered in large doses, oleic acid caused scaling and reversible hair loss on
the ears of the animals. The baldness had the same features as the local depilation
produced by oleic acid.
3. In large amounts, the methyl, phenyl ethers and palmitic ester of vitamin A
inactivated sulfhydryl groups and the sulfhydryl enzyme succinic dehydrogenase.
The methyl ether caused hair loss in mice after local application, while the phenyl
ether was inactive.
4. Hydroxenin and oxenin, synthetic precursors in the manufacture of vitamin
A, had the same in vitro effects as the ethers of vitamin A.
5. Diminution of scaling in patients with ichthyosis was observed after local
application of hydroxenin ointment. Oxenin had no effect.
6. These findings support our previous supposition that in large amounts vita-
min A has a direct, local, non-specific action on the epidermal cells. This effect is
probably due to interference with the sulfhydryl metabolism of the epidermis.
The active principle may be an as yet unidentified intermediary metabolic
degradation product of vitamin A.
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DISCUSSION
DR. STEPHEN ROThMAN, Chicago, Illinois: In his remarkable series of experi-
ments, Dr. Flesch has conclusively demonstrated that the biological effect of
Vitamin A on the epidermis is due to a certain chemical configuration and that
other compounds not having vitamin action but the same chemical grouping
have the same effect. Thereby he has shown that this is not a vitamin effect.
I wonder if the picture he has shown us was actually a case of ichthyosis vul-
garis because it showed involvement of the antecubital fossa while in ichthyosis
vulgaris this fossa is never involved. Also I wonder if the therapeutic effects
achieved with local application of vitamin A have any clinical significance. Can't
as good results be obtained with any ointment base containing low concentra-
tions of salicylic acid?
I also would like to ask whether it is not an over-simplification to attribute the
complex and amazing metaplasia of keratinizing embryonic epithelium into a
ciliated mucus-producing mucous membrane, as shown by S. Fell, to inhibition
of sulfhydryl function. Is there any reason to assume that mucous membrane
cells require less sulfhydryl-dependent enzymes than do the epidermal cells?
DR. FREDERICK REISS, New York, N. Y.: I have been not only impressed by
the excellent contributions of Dr. Flesch, but added impetus was given to me by
Dr. Sabelia's investigations, (Proc. Soc. Exp. Biol. & Med. 76: 499, 1951). The
topical application of vitamin A to oophorectomized rats resulted in an average
increase in epidermal thickness to about twice normal.
About two years ago, I investigated with Dr. Campbell (Department of
Plastic Surgery, New York University Medical School) the effect of locally
applied vitamin A to the senile skin. We have not used large doses as Dr. Flesch,
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but only 3,000 vitamin A palmitate per ounce. In most patients, an appreciable
improvement was seen in the dryness of the skin, scale formation, and fofficular
hyperkeratosis, which was not observed to such a degree in the control side
using the base alone.
In relation to Dr. Rothman's question, I may be able to give an explanatory
answer. The effect of vitamin A is clearly seen in obvious histologic changes. Our
slides have been recently reviewed by Dr. Harman of the Department of Anat-
omy, New York University Medical School, who found in the vitamin A treated
skin, noticeable changes in contrast to the controls. These changes consist mainly
of the presence of many cells with pyknotic nuclei and an increase of keratohyalin
granules. Pucinelli (Giorn. ital. dermat. 83: 840, 1948) applied vitamin A con-
taining ointment in cases of lichen planus and psoriasis, and although no clinical
improvement was recorded, histologic changes are similar to those observed in
our investigations.
DR. MARION B. SULZBERGER, New York, N. Y.: In a carefully studied but still
all too small series of cases Dr. Leah Fisher in our Department at the Skin and
Cancer Unit has as yet been unable to show any regular substantial effect of
locally applied vitamin A on the scaling of cases of ichthyosis. I don't know what
the reason for the failures may be. I believe that Dr. Fisher's cases were all males
and there may be a sex determined difference in response. In carefully controlled
observations with contralateral comparison with blank control vehicles, no
diminution of scaling, no clinical improvement could be observed in certain
cases. In histologic studies, which are still unfinished and not yet ready for any
definitive statement her careful (and tedious) planimetric measurements of the
thickness of the stratum corneum and of the other layers of the epithelium evi-
denced no regular effects of the vitamin A inunctions when compared with con-
trol sites inuncted with vehicles alone. Maybe Dr. Fisher is here and will want
to say something about the present status of her planimetric and clinical studies.
Then I would like to call attention to some remarks that appeared in the in-
troduction of the Yearbook of Dermatology and Syphiology for the years 1938
and 1941. These stated that the systemic administration of vitamin A was being
effective in a large series of dermatoses characterized by abnormal keratinization,
either follicular or non-fofficular. The effect was not due to overcoming a dietary
vitamin A deficiency—because the doses needed were far in excess of that which
one would expect if this was a dietary vitamin effect, i.e. the doses necessary were
far in excess of the daily dietary requirements. Moreover, the patients that
received these benefits had no other evidence whatsoever of either a dysvita-
minosis or a dietary vitamin deficiency.
DR. R. L. MAYER, Summit, N. J.: Dr. Flesch's investigations are of great
theoretical interest because they seem to explain the role of certain lipids and
especially unsaturated fatty acids in the skin. So far we have always looked at the
skin lipids as serving for the lubrication of the hair and the skin. But it is quite
possible that lipids, especially those rich in unsaturated fatty acids play an active
role in skin metabolism. As with vitamin A, they may form redox systems as in
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the case of many proteinic enzymes, and are actively engaged in the metabolism
of energy-rich products. We were able to show in our own experiments that
bacterial lipids, which have long been considered as simple protective agents
play such an active role.
Dx. SAMUEL M. PECK, New York, N. V.: I have been stimulated for a number
of years by Dr. Flesch's experiments. Since the initial experiments which we
carried on in Darier's disease and ichthyosis our findings seemed at variance.
Once was that while we believed that in a disease like Darier's we produced our
vitamin A effect because here we felt was an abnormality in metabolism of vita-
min A, we were unable to find either blood levels or other indications for such an
assumption in ichthyosis. Yet we too noted that large doses of vitamin A, both
locally and parenterally seemed to affect the ichthyotic skin favorably.
Insight into the effects of vitamin A in large doses in ichthyosis and other
conditions with hyperkeratosis is now explained by Dr. Flesch's experiments.
I believe, however, that diseases which have hyperkeratosis as a manifestation
can be divided into two distinct types. (1) One is that we have a real dyskeratosis
so that a receptor mechanism for vitamin A is abnormal. Such cases actually
need relatively smaller doses to obtain effects than those in which we have
ordinary hyperkeratosis with a normal vitamin A metabolism. (2) In ordinary
follicular keratosis which is not due to a proven vitamin A deficiency or an
abnormality in vitamin A metabolism even very large doses of vitamin A may
cause no effects, or will give little, if any, changes. Skin diseases which are
characterized by excessive parakeratosis fall somewhat in between these two
groups. An example of this group is psoriasis. I have no reason to believe that an
abnormal vitamin A metabolism plays a role in psoriasis. However, intramuscular
injections of vitamin A in fairly large doses will cause a drop in blood levels in
some psoriatics in contradistinction to the usual rise in normal patients. At the
same time, the injections of vitamin A may favorably influence the course of
psoriasis in some instances.
DR. THEODORE C0RNBLEET, Chiaego, Ill.: I presume Doctor Flesch refers to
the nonspecific effects of vitamin A on the skin as action other than that of normal
physiological keratinization. This latter power must be by indirect means, be-
cause we found no vitamin A as such on or in the normal skin. Doctor Flesch
felt massive doses of oleic acid spilled over on the skin. Are there iodine number
studies to corroborate his opinion? Doctor Peck pointed out that in Darier's
and Devergie's diseases the blood vitamin A level may be normal. We found not
only this may be true of the blood, but also the vitamin A stores in the liver are
normal in both diseases.
Dx. PETER FLESCH (in dosing): I would like to thank those participating in the
discussion for their kind remarks.
In answer to Dr. Rothman, the picture of alleged ichthyosis shown was indeed
the anticubital fossa of a patient, diagnosed as ichthyosis simplex. We should
have classified her as congenital ichthyosiform erythroderma. I am inclined to
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believed that ichthyosis is used as a general term under which we discuss diseases
which may look somewhat similar, but are probably different in their patho-
genesis.
Fell's work is unfortunate in one respect, at least as far as dermatologists are
concerned: she worked with chick embryos and not with mammalian skin. I
don't think one can expect the same changes to occur in the epidermal cells of
the mucous membranes of mammals as has been observed by her in the chick
embryo. In the mouse, Dr. Fell found inhibition of hair formation in vitro, a
study which is just briefly mentioned in her present work.
Inhibition of sulfhydryl groups may be limited to certain specific sites. For
example, X-rays primarily inactivate the sulfhydryl groups of the cells of the
hair follicles; vesicants affect mostly the sulfhydryl groups of the capillary endo-
thelium. The solubility of the inhibitor may be a decisive factor in this respect.
I cannot recommend the routine use of local vitamin A ointments. First of all,
this type of treatment is expensive. Then the results often are not better than
one could obtain with other methods. I am not at all convinced, that, with the
exception of some cases, the local treatment with vitamin A offers any advantage
over more conservative methods.
In answer to Dr. Sulzberger's comment about failure of local vitamin A in
ichthyosis, I wish to point out that in my original work I described six patients
treated with local vitamin A in two of whom no beneficial effect was seen. As far
as the mode of action of vitamin A is concerned, I could quote Dr. Sulzberger as
supporting both the idea that vitamin A acts because of an alleged local hypo-
vitaminosis ("dysvitaminosis") or because it has a pharmacological effect. To
the best of my knowledge, the latest statement on this subject has been made in
the Yearbook of 1949 (p. 13—14). In the same paragraph it is mentioned that
acne may be due to a localized high requirement for vitamin A or vitamin A
may have a purely pharmacological effect in this condition.
I am very grateful for Dr. Mayer's remarks and would like to call his attention
to the fact that similar speculations about the possible enzymatic role of vitamin
A have been raised in the past. It has been observed that when yeast cells were
grown under high oxygen pressure, they were able to synthesize vitamin A, while
normally they were not able to do so. (J. Exp. Cell Res., 1: 494, 1950). This may
indicate that under certain conditions yeast acquires an enzyme system which
requires vitamin A for its functioning.
We did not carry out iodine number determinations of surface fats. Such work
has been done in the past by Perutz et al. (Arch. Derm. u. Syph., 170: 511, 1934)
who injected cod liver oil into rabbits and observed decreased hair growth with
an increase in the iodine number of the skin fats.
Concerning the physiological and pharmacological effects of vitamin A, I may
have been too rigid in the past in order to drive a point home. A strict distinction
between these two effects may be impossible. The two effects may overlap to a
certain extent. After all, the physiological effect must take place through some
chemical reaction and it is possible that the so-called drug effect is merely an
accentuation of a normal physiological effect.
